Literature DB >> 27325049

Therapeutic Strategies for Hereditary Kidney Cancer.

Abhinav Sidana1, Ramaprasad Srinivasan2.   

Abstract

The study of hereditary forms of kidney cancer has vastly increased our understanding of metabolic and genetic pathways involved in the development of both inherited and sporadic kidney cancers. The recognition that diverse molecular events drive different forms of kidney cancers has led to the preclinical and clinical development of specific pathway-directed strategies tailored to treat distinct subgroups of kidney cancer. Here, we describe the molecular mechanisms underlying the pathogenesis of several different types of hereditary renal cancers, review their clinical characteristics, and summarize the treatment strategies for the management of these cancers.

Entities:  

Keywords:  Clear cell renal cell cancer; Fumarate hydratase; HLRCC; HPRC; Hereditary; Inherited; Kidney cancer; Metastatic; Papillary renal cell cancer; Renal cell cancer; Succinate dehydrogenase; Tuberous sclerosis; Tyrosine kinase inhibitors; Von Hippel-Lindau

Mesh:

Substances:

Year:  2016        PMID: 27325049     DOI: 10.1007/s11912-016-0537-6

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  53 in total

1.  Inherited susceptibility to uterine leiomyomas and renal cell cancer.

Authors:  V Launonen; O Vierimaa; M Kiuru; J Isola; S Roth; E Pukkala; P Sistonen; R Herva; L A Aaltonen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

2.  Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery.

Authors:  M M Walther; P L Choyke; G Glenn; J C Lyne; W Rayford; D Venzon; W M Linehan
Journal:  J Urol       Date:  1999-05       Impact factor: 7.450

3.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

4.  Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas.

Authors:  L Schmidt; F M Duh; F Chen; T Kishida; G Glenn; P Choyke; S W Scherer; Z Zhuang; I Lubensky; M Dean; R Allikmets; A Chidambaram; U R Bergerheim; J T Feltis; C Casadevall; A Zamarron; M Bernues; S Richard; C J Lips; M M Walther; L C Tsui; L Geil; M L Orcutt; T Stackhouse; J Lipan; L Slife; H Brauch; J Decker; G Niehans; M D Hughson; H Moch; S Storkel; M I Lerman; W M Linehan; B Zbar
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

Review 5.  Papillary renal cell carcinoma: A review of the current therapeutic landscape.

Authors:  Giulia Courthod; Marcello Tucci; Massimo Di Maio; Giorgio V Scagliotti
Journal:  Crit Rev Oncol Hematol       Date:  2015-05-27       Impact factor: 6.312

6.  Evaluation and management of renal tumors in the Birt-Hogg-Dubé syndrome.

Authors:  Christian P Pavlovich; Robert L Grubb; Kathleen Hurley; Gladys M Glenn; Jorge Toro; Laura S Schmidt; Carlos Torres-Cabala; Maria J Merino; Berton Zbar; Peter Choyke; McClellan M Walther; W Marston Linehan
Journal:  J Urol       Date:  2005-05       Impact factor: 7.450

Review 7.  Aerobic glycolysis: a novel target in kidney cancer.

Authors:  Brian Shuch; W Marston Linehan; Ramaprasad Srinivasan
Journal:  Expert Rev Anticancer Ther       Date:  2013-06       Impact factor: 4.512

8.  Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriers.

Authors:  Umasuthan Srirangalingam; Lisa Walker; Bernard Khoo; Fiona MacDonald; Daphne Gardner; Terence J Wilkin; Robert H Skelly; Emad George; David Spooner; John P Monson; Ashley B Grossman; Scott A Akker; Patrick J Pollard; Nick Plowman; Norbert Avril; Daniel M Berney; Jacky M Burrin; Rodney H Reznek; V K Ajith Kumar; Eamonn R Maher; Shern L Chew
Journal:  Clin Endocrinol (Oxf)       Date:  2008-04-14       Impact factor: 3.478

9.  Germline SDHB mutations and familial renal cell carcinoma.

Authors:  Christopher Ricketts; Emma R Woodward; Pip Killick; Mark R Morris; Dewi Astuti; Farida Latif; Eamonn R Maher
Journal:  J Natl Cancer Inst       Date:  2008-08-26       Impact factor: 13.506

10.  Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer.

Authors:  Christopher J Ricketts; Brian Shuch; Cathy D Vocke; Adam R Metwalli; Gennady Bratslavsky; Lindsay Middelton; Youfeng Yang; Ming-Hui Wei; Stephen E Pautler; James Peterson; Catherine A Stolle; Berton Zbar; Maria J Merino; Laura S Schmidt; Peter A Pinto; Ramaprasad Srinivasan; Karel Pacak; W Marston Linehan
Journal:  J Urol       Date:  2012-10-18       Impact factor: 7.450

View more
  3 in total

Review 1.  Role of Positron Emission Tomography Imaging in Metabolically Active Renal Cell Carcinoma.

Authors:  Vidhya Karivedu; Amit L Jain; Thomas J Eluvathingal; Abhinav Sidana
Journal:  Curr Urol Rep       Date:  2019-08-29       Impact factor: 3.092

Review 2.  Hereditary Renal Tumor Syndromes: Update on Diagnosis and Management.

Authors:  Sonia Gaur; Baris Turkbey; Peter Choyke
Journal:  Semin Ultrasound CT MR       Date:  2016-10-14       Impact factor: 1.875

3.  Intra-tumour molecular heterogeneity of clear cell renal cell carcinoma reveals the diversity of the response to targeted therapies using patient-derived xenograft models.

Authors:  Baoan Hong; Yong Yang; Sheng Guo; Shayiremu Duoerkun; Xiaohu Deng; Dawei Chen; Shijun Yu; Wubin Qian; Qixiang Li; Qing Li; Kan Gong; Ning Zhang
Journal:  Oncotarget       Date:  2017-07-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.